Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar 18:5:24.
doi: 10.3389/fcimb.2015.00024. eCollection 2015.

Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype

Elias A Rahal  1 , Sukayna M Fadlallah  1 , Farah J Nassar  1 , Natalie Kazzi  1 , Ghassan M Matar  1
Affiliations
Review

Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype

Elias A Rahal et al. Front Cell Infect Microbiol. .

Abstract

Shiga toxin-producing Escherichia coli (STEC) are a group of diarrheagenic bacteria associated with foodborne outbreaks. Infection with these agents may result in grave sequelae that include fatality. A large number of STEC serotypes has been identified to date. E. coli serotype O104:H4 is an emerging pathogen responsible for a 2011 outbreak in Europe that resulted in over 4000 infections and 50 deaths. STEC pathogenicity is highly reliant on the production of one or more Shiga toxins that can inhibit protein synthesis in host cells resulting in a cytotoxicity that may affect various organ systems. Antimicrobials are usually avoided in the treatment of STEC infections since they are believed to induce bacterial cell lysis and the release of stored toxins. Some antimicrobials have also been reported to enhance toxin synthesis and production from these organisms. Various groups have attempted alternative treatment approaches including the administration of toxin-directed antibodies, toxin-adsorbing polymers, probiotic agents and natural remedies. The utility of antibiotics in treating STEC infections has also been reconsidered in recent years with certain modalities showing promise.

Keywords: Shiga toxin 1; Shiga toxin 2; Shiga toxin-producing Escherichia coli; antimicrobial agents; hemolytic uremic syndrome; hemorrhagic colitis.

PubMed Disclaimer

References

    1. Abuladze T., Li M., Menetrez M. Y., Dean T., Senecal A., Sulakvelidze A. (2008). Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7. Appl. Environ. Microbiol. 74, 6230–6238. 10.1128/AEM.01465-08 - DOI - PMC - PubMed
    1. Anany H., Chen W., Pelton R., Griffiths M. W. (2011). Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes. Appl. Environ. Microbiol. 77, 6379–6387. 10.1128/AEM.05493-11 - DOI - PMC - PubMed
    1. Asahara T., Shimizu K., Nomoto K., Hamabata T., Ozawa A., Takeda Y. (2004). Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 72, 2240–2247. 10.1128/IAI.72.4.2240-2247.2004 - DOI - PMC - PubMed
    1. Asper D. J., Karmali M. A., Townsend H., Rogan D., Potter A. A. (2011). Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans. Clin. Vaccine Immunol. 18, 1052–1057. 10.1128/CVI.00068-11 - DOI - PMC - PubMed
    1. Auvray F., Dilasser F., Bibbal D., Kerouredan M., Oswald E., Brugere H. (2012). French cattle is not a reservoir of the highly virulent enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4. Vet. Microbiol. 158, 443–445. 10.1016/j.vetmic.2012.02.029 - DOI - PubMed

MeSH terms